Zurich Cantonal Bank’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10
Closed -$1.64K 2650
2024
Q1
$1.64K Hold
10
﹤0.01% 2661
2023
Q4
$1.17K Sell
10
-31
-76% -$2.69K ﹤0.01% 2696
2023
Q3
$3.52K Sell
41
-7
-15% -$892 ﹤0.01% 2758
2023
Q2
$7.21K Sell
48
-14
-23% -$2.41K ﹤0.01% 2753
2023
Q1
$8.27K Buy
+62
New +$11.2K ﹤0.01% 2805
2022
Q2
Sell
-53
Closed -$13K 2894
2022
Q1
$13K Hold
53
﹤0.01% 2697
2021
Q4
$52K Hold
53
﹤0.01% 2721
2021
Q3
$79K Buy
+53
New +$103K ﹤0.01% 2457

Other funds holding BCAB

Zurich Cantonal Bank's BCAB Position: Q2 2024 in Review

Zurich Cantonal Bank sold out of BioAtla (BCAB) in Q2 2024, closing a stake of 10 shares — an estimated $1.64K sold.

Zurich Cantonal Bank first reported a position in BCAB in Q3 2021 and held it in 8 quarters. The position peaked at $79K in Q3 2021. 80 funds tracked by Wall St. Rank hold BCAB as of Q2 2024.

  • Zurich Cantonal Bank reported no remaining BioAtla position as of Q2 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 10 BioAtla shares in Q2 2024, an estimated $1.64K.
  • Zurich Cantonal Bank first reported a position in BioAtla in Q3 2021 and held it in 8 quarters.
  • Zurich Cantonal Bank's BioAtla position peaked at $79K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held BioAtla as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.